- Home
- NRSN vs INM Comparison
NRSN vs INM Comparison
Compare NRSN & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | INM |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NRSN | INM |
|---|---|---|
| Price | $1.44 | $14.00 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $91.75 | N/A |
| AVG Volume (30 Days) | 36.8K | ★ 64.4K |
| Earning Date | 09-25-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.25 | $0.58 |
| 52 Week High | $7.50 | $2.33 |
Technical Indicators
Market Signals| Indicator | NRSN | INM |
|---|---|---|
| Relative Strength Index (RSI) | 31.32 | 99.23 |
| Support Level | $0.61 | $1.00 |
| Resistance Level | $7.50 | N/A |
| Average True Range (ATR) | 0.33 | 0.50 |
| MACD | -0.10 | 1.24 |
| Stochastic Oscillator | 24.85 | 84.72 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.